Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Blood System Drugs > Anifrolumab API Monoclonal Antibody
Anifrolumab API Monoclonal Antibody buy - large image1
Anifrolumab API Monoclonal Antibody buy - image1

Anifrolumab API Monoclonal Antibody

Unit Price:

$4812/UNIT EXW

Get Latest Price
Packaging:

1

Price valid (until):

2027-10-20

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Active Pharmaceutical Ingredient (API)

  • Product Details

  • Seller Information

  • Description


      Product Detail  


    Anifrolumab API – Monoclonal Antibody

    Product Overview

    Anifrolumab is a human monoclonal antibody targeting the type I interferon receptor (IFNAR1). It is a biologic active pharmaceutical ingredient intended for pharmaceutical development and manufacturing, subject to applicable regulatory requirements.

    Product Information

    • Product Name: Anifrolumab

    • Product Type: Biologic API

    • Molecular Type: Human Monoclonal Antibody (IgG1)

    • Target: Type I Interferon Receptor Subunit 1 (IFNAR1)

    • CAS Number: To be confirmed

    • Appearance: As specified in the approved product specification

    • Purity: As stated in the current Certificate of Analysis (COA)

    • Packaging: To be confirmed

    • Storage Conditions: As specified by the manufacturer

    • Shelf Life: As specified by the manufacturer

    Quality Documentation

    Product-specific quality documentation may include the Certificate of Analysis (COA), technical data sheet (TDS), applicable manufacturing and quality documentation, and relevant regulatory registration information, subject to availability and authorization.

    Supply Information

    Available specifications, batch size, packaging options, minimum order quantity, sample availability, lead time, and commercial terms are subject to confirmation.

    Please request the current product specification and supporting quality documentation for technical evaluation before placing an order.

    Basic Info
    Product Name:

    Anifrolumab; Anifrolumab API; Monoclonal Antibody; Human IgG1 Antibody; IFNAR1 Targeted Antibody; Biopharmaceutical API

    Categories:

    Blood System Drugs

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Active Pharmaceutical Ingredient (API)

    Location:

    Unit 102, Jinyang Castle, No. 6 East Dongping Rd, Yongping Subdistrict, Baiyun District, Guangzhou, China

    Total Employees:

    51-100

    Year of Establishment:

    2026

    DengYuePharmacy is a fully licensed Chinese pharmaceutical institution dedicated to cross-border healthcare services linking China’s pharma sector to global demand.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.